Eye scans for hydroxychloroquine users
Part of Eyes & vision clinical trials.
This study uses special eye scans to look for early signs of damage in people who have been taking hydroxychloroquine for at least a year. It aims to help doctors monitor eye health more closely during treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been taking hydroxychloroquine for at least 1 year.
- Your condition (for which you take the drug) is stable under a doctor's care.
- You do not have any eye diseases like diabetic retinopathy, macular degeneration, or certain vision problems.
- You have not had eye surgery or a serious eye injury.
- You do not have uncontrolled high blood pressure or other blood vessel diseases.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of eye test (ERG) to detect early damage from hydroxychloroquine, a drug used for conditions like lupus and rheumatoid arthritis. If you take hydroxychloroquine or have never taken it, you might help find better ways to protect your vision.
This study uses a special, high-detail eye imaging machine to take clear pictures of the outer retina. It may help researchers understand these eye conditions better, and how the eye images look when people have an outer retinal disease.
This study uses artificial intelligence to look at eye images of people who have taken hydroxychloroquine for a long time. The goal is to better detect or predict early signs of retinal damage, so you can get the right care sooner.
This study looks at how Plaquenil (hydroxychloroquine) can harm the retina (the eye’s light-sensing layer) and whether genetics affect who gets affected. You may help by sharing medical details and providing an eye-related blood sample so researchers can compare gene patterns to eye findings.
This study looks at whether it is safe for people aged 55 and older with long-standing, stable lupus to stop taking hydroxychloroquine (a medicine that helps control lupus) without their disease flaring up. If you have been taking this medicine for at least 7 years and your lupus has been quiet for a while, you may be able to join.
This study tests whether hydroxychloroquine can slow the progression of Parkinson's disease. It is for people who have been diagnosed with Parkinson's within the last 4 years and are not yet in advanced stages.
Hear when a new Hydroxychloroquine Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.